{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T13:03:56Z","timestamp":1726405436002},"reference-count":41,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2205,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Cardiol"],"DOI":"10.1002\/clc.4960281310","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T12:16:52Z","timestamp":1278505012000},"page":"58-63","source":"Crossref","is-referenced-by-count":0,"special_numbering":"supplement S1","title":["Real-world algorithms for the optimal use of drugs and devices in the patient post myocardial infarction and the future of post myocardial infarction management"],"prefix":"10.1002","volume":"28","author":[{"given":"Todd J.","family":"Rudo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,18]]},"reference":[{"key":"10.1002\/clc.4960281310-BIB1|cit1","first-page":"12","article-title":"Sudden cardiac death. Structure, function, and time-dependence of risk","volume":"85","author":"Myerburg","year":"1992","journal-title":"Circulation"},{"key":"10.1002\/clc.4960281310-BIB2|cit2","first-page":"123","article-title":"State-specific mortality from sudden cardiac death-United States, 1999","volume":"51","year":"2002","journal-title":"MMWR"},{"key":"10.1002\/clc.4960281310-BIB3|cit3","first-page":"198","article-title":"Community-based interventions for sudden cardiac death. Impact, limitations, and changes","volume":"85","author":"Cobb","year":"1992","journal-title":"Circulation"},{"key":"10.1002\/clc.4960281310-BIB4|cit4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJMoa040566","article-title":"Public-access defibrillation and survival after out-of-hospital cardiac arrest","volume":"351","author":"Hallstrom","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281310-BIB5|cit5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(96)08171-8","article-title":"Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators","volume":"349","author":"Cairns","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281310-BIB6|cit6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(96)09145-3","article-title":"Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators","volume":"349","author":"Julian","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281310-BIB7|cit7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281310-BIB8|cit8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ehj.2004.03.013","article-title":"Effects of pravastatin on coronary events in 2,073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: Results from the LIPID study","volume":"25","author":"Colquhoun","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1002\/clc.4960281310-BIB9|cit9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281310-BIB10|cit10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol","volume":"348","author":"Waldo","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281310-BIB11|cit11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281310-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(82)92225-5","article-title":"Controlled trial of sotalol for one year after myocardial infarction","volume":"1","author":"Julian","year":"1982","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281310-BIB13|cit13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281310-BIB14|cit14","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","author":"AIRE Study Investigators","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281310-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960281310-BIB16|cit16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators","volume":"325","author":"SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281310-BIB17|cit17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281310-BIB18|cit18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281310-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281310-BIB20|cit20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(81)91101-6","article-title":"Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial","volume":"2","author":"Hjalmarson","year":"1981","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281310-BIB21|cit21","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group","volume":"2","author":"ISIS-1 Collaborative Group","year":"1986","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281310-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial","volume":"357","author":"CAPRICORN Investigators","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281310-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1053\/euhj.1999.1984","article-title":"Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: Double-blind, randomized, placebo-controlled study","volume":"21","author":"Cice","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1002\/clc.4960281310-BIB24|cit24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3940(94)90609-2","article-title":"Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor","volume":"171","author":"Lysko","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1002\/clc.4960281310-BIB25|cit25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000138616","article-title":"In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol","volume":"39","author":"Nichols","year":"1989","journal-title":"Pharmacology"},{"key":"10.1002\/clc.4960281310-BIB26|cit26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0008-6363(00)00265-0","article-title":"Antiarrhythmic drug carvedilol inhibits HERG potassium channels","volume":"49","author":"Karle","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1002\/clc.4960281310-BIB27|cit27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction. Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial","volume":"45","author":"McMurray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960281310-BIB28|cit28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mhj.2001.117318","article-title":"Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: Retrospective analysis of the US Carvedilol Heart Failure Trials Program","volume":"142","author":"Joglar","year":"2001","journal-title":"Am Heart J"},{"key":"10.1002\/clc.4960281310-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?","volume":"42","author":"Khand","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960281310-BIB30|cit30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.CIR.96.1.183","article-title":"Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial","volume":"96","author":"Basu","year":"1997","journal-title":"Circulation"},{"key":"10.1002\/clc.4960281310-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281310-BIB32|cit32","first-page":"3G","article-title":"Metoprolol in acute myocardial infarction. Patients and methods. The MIAMI Trial Research Group","volume":"56","author":"MIAMI Trial Research Group","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960281310-BIB33|cit33","first-page":"15G","article-title":"Metoprolol in acute myocardial infarction. Mortality. The MIAMI Trial Research Group","volume":"56","author":"MIAMI Trial Research Group","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960281310-BIB34|cit34","doi-asserted-by":"crossref","first-page":"23G","DOI":"10.1016\/0002-9149(85)90692-7","article-title":"Metoprolol in acute myocardial infarction. Development of myocardial infarction","volume":"56","author":"MIAMI Trial Research Group","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960281310-BIB35|cit35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"key":"10.1002\/clc.4960281310-BIB36|cit36","first-page":"735","article-title":"A multicentre international study","volume":"3","author":"Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol.","year":"1975","journal-title":"Br Med J"},{"key":"10.1002\/clc.4960281310-BIB37|cit37","first-page":"149","article-title":"The Norwegian Multicenter Study of Timolol after Myocardial Infarction","volume":"67","author":"Pedersen","year":"1983","journal-title":"Circulation"},{"key":"10.1002\/clc.4960281310-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results","volume":"247","author":"Beta-Blocker Heart Attack Trial Research Group","year":"1982","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960281310-BIB39|cit39","first-page":"189","article-title":"A secondary prevention study with slow release oxprenolol after myocardial infarction: Morbidity and mortality","volume":"5","author":"European Infarction Study (E.I.S.)","year":"1984","journal-title":"Eur Heart J"},{"key":"10.1002\/clc.4960281310-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/oxfordjournals.eurheartj.a062170","article-title":"The Lopressor Intervention Trial: Multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group","volume":"8","author":"Lopressor Intervention Trial Research Group","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1002\/clc.4960281310-BIB41|cit41","first-page":"1429","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960281310","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/clc.4960281310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T22:56:03Z","timestamp":1625180163000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960281310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,18]]},"references-count":41,"journal-issue":{"issue":"S1"},"URL":"https:\/\/doi.org\/10.1002\/clc.4960281310","relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"type":"print","value":"0160-9289"},{"type":"electronic","value":"1932-8737"}],"subject":[],"published":{"date-parts":[[2009,8,18]]}}}